Specialties

Respiratory Medicine

Breathlessness, airways disease and the pleura

The Respiratory Medicine engine looks at breathlessness and hypoxia as a chest physician would: what type of respiratory failure this is, how wide the A-a gradient is, and whether the cause lies in the airways, the parenchyma, the pulmonary vessels or outside the lungs. It grades asthma and COPD exacerbations on objective criteria, applies the severity and probability scores, and interprets spirometry, gases and pleural fluid in a fixed order.

Who it is for

  • Medical registrars and residents managing respiratory admissions on the take
  • Respiratory trainees and physicians reviewing gases, spirometry or pleural results
  • Emergency doctors deciding on NIV, admission or discharge for breathless patients

What it does

  • The type of respiratory failure

    Classifies failure as type 1 or type 2 from the blood gas, calculates the A-a gradient, and sorts the causes of breathlessness into cardiac, pulmonary, pulmonary vascular, neuromuscular, metabolic and anaemic.

  • Asthma and COPD exacerbations

    Grades severity by peak flow, speech, respiratory rate, saturation and gas; sets out stepwise acute treatment, controlled oxygen at 88 to 92% when hypercapnia is a risk, NIV indications and critical care criteria, then long-term care by GINA and GOLD.

  • Pneumonia severity and treatment

    Scores severity with CURB-65 or the Pneumonia Severity Index, considers the likely organisms for the setting and the host, and gives treatment and duration according to the applicable guideline.

  • Pulmonary embolism from suspicion to disposition

    Estimates pre-test probability with Wells or Geneva, applies PERC, YEARS and an age-adjusted D-dimer where they fit, then uses PESI or sPESI, right ventricular strain and troponin to choose outpatient care, admission or reperfusion.

  • Pleural fluid

    Applies Light's criteria, reads pleural pH, glucose and cytology together, and identifies the features of pleural infection that call for chest drainage.

  • Spirometry, nodules and pneumothorax

    Reads spirometry in order (quality, FEV1/FVC against the lower limit of normal, severity, reversibility, volumes and gas transfer), follows Fleischner or BTS guidance for nodules, and manages pneumothorax by size, symptoms and underlying lung disease.

How it works

  1. The clinician enters the presenting problem and its timeline, saturation and oxygen requirement, respiratory rate and smoking history, any gas, spirometry or pleural results, and the chest imaging findings.
  2. The engine identifies the type and severity of respiratory failure and flags features that need escalation, such as a rising carbon dioxide in acute asthma.
  3. It applies the severity, probability and interpretation criteria that fit the problem and shows each calculation.
  4. It retrieves BTS, ERS, ATS, GINA and GOLD guidance, systematic reviews and trials from PubMed and cites them by number.
  5. It returns the differential, the work-up and the management plan, typically in under a minute.

What to include

  • Age, sex and the presenting problem with its timeline
  • SpO2 and oxygen requirement, respiratory rate, smoking history
  • Blood gas, spirometry or pleural fluid results
  • Chest imaging findings

Example cases

  • COPD exacerbation, pH 7.29, PaCO2 68 mmHg on 28% oxygen, drowsy. Is NIV indicated and how should it be set up?
  • Unilateral pleural effusion: fluid protein 41 g/L, LDH 380, glucose 2.1, pH 7.18. Interpretation and next step?
  • 45F with wheeze, FEV1/FVC 0.62, FEV1 58% predicted, 320 mL reversibility. Diagnosis and stepwise treatment?

What the report contains

  1. Differential diagnosis
  2. Recommended work-up
  3. Management plan
  4. Verified references

Limits

  • It cannot see the patient. Work of breathing, the ability to complete sentences and drowsiness reach it only as typed, and a tiring patient with asthma can look reassuring on numbers alone.
  • Chest imaging and spirometry are read from the report text or images supplied; an image read here does not replace a radiologist's report or a formal lung function report.
  • Antibiotic choice depends on local resistance and formulary, and BTS, NICE, ATS/IDSA, GINA and GOLD differ in detail. Local protocols take precedence.

Frequently asked questions

How is the A-a gradient calculated?

Alveolar oxygen is estimated as FiO2 multiplied by (barometric pressure minus water vapour pressure), minus PaCO2 divided by 0.8. On room air at sea level that is roughly 150 minus PaCO2/0.8 in mmHg. The gradient is alveolar minus arterial oxygen; it widens with age, and a raised gradient points to a lung or pulmonary vascular cause rather than hypoventilation alone.

When is non-invasive ventilation indicated in a COPD exacerbation?

When acute hypercapnic respiratory acidosis, a pH of 7.35 or below with a raised PaCO2, persists despite optimal medical treatment and controlled oxygen. Drowsiness, a falling pH or failure to improve on NIV should prompt early senior and critical care review, with a documented plan for what happens if NIV fails.

What are Light's criteria for pleural effusion?

A pleural effusion is an exudate if any one applies: pleural fluid to serum protein ratio above 0.5, pleural fluid to serum LDH ratio above 0.6, or pleural fluid LDH above two-thirds of the upper limit of normal for serum LDH. A low pH or glucose in an exudate raises the concern of pleural infection.

What oxygen saturation target should be used in COPD?

For patients at risk of hypercapnic respiratory failure, including most with COPD, BTS guidance targets 88 to 92% with controlled oxygen until a blood gas is available; for most other acutely ill adults the target is 94 to 98%. The target should be prescribed and reviewed against the gas.